Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
New Drug Application
Sort By
Newest First
1 / 1
1 / 1
NDA
Clearside Biomedical Provides New Drug Application Update for XIPEREᵀᴹ (triamcinolone acetonide suprachoroidal injectable suspension)
Clearside Biomedical
PR-M08-19-NI-077
Aug 27, 2019
New Drug Application
Janssen Submits Supplemental New Drug Application to U.S. FDA for INVOKANA® (canagliflozin) for the Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes
Janssen Pharmaceutical Companies
PR-M04-19-NI-008
Apr 02, 2019
Macular Degeneration
More Positive Results for Novartis Eye Drug Brolucizumab
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M11-18-NI-002
Nov 05, 2018
New Drug Application
Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer
Janssen Pharmaceutical Companies
PR-M09-18-NI-083
Sep 26, 2018
NDA
Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII™ (halobetasol propionate and tazarotene) Lotion
Ortho Dermatologics
PR-M09-18-NI-057
Sep 19, 2018
Drug Application
Nektar Therapeutics Announces New Drug Application for NKTR-181 Accepted for Review by FDA
Nektar Therapeutics
PR-M08-18-NI-011
Aug 03, 2018
Drug Application
FDA Accepts Larotrectinib New Drug Application and Grants Priority Review
Bayer
PR-M05-18-NI-115
May 31, 2018
